BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6530734)

  • 1. [A computerized method for the administration of heparin and protamine during open-heart surgery].
    Isshiki A; Sakaguchi Y; Kubota K; Ikeda T
    Masui; 1984 Dec; 33(12):1323-8. PubMed ID: 6530734
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitoring of blood coagulation in open heart surgery. I. Effects of conventional dosages of heparin and protamine.
    Dercksen SJ; Linssen GH
    Acta Anaesthesiol Belg; 1980; 31(2):113-9. PubMed ID: 7468137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of blood coagulation in open heart surgery. II. Use of individualized dosages of heparin and protamine controlled by activated coagulation times.
    Dercksen SJ; Linssen GH
    Acta Anaesthesiol Belg; 1980; 31(2):121-8. PubMed ID: 7468138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Heparin monitoring during cardiopulmonary bypass in congenital heart surgery].
    Isomatsu Y; Imai Y; Seo K; Terada M; Aoki M; Shin'oka T
    Kyobu Geka; 2000 Nov; 53(12):1001-4. PubMed ID: 11079303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Protamine dosage for heparin neutralization in open-heart surgery (author's transl)].
    Shiao K
    Fukuoka Igaku Zasshi; 1974 Nov; 65(11):878-88. PubMed ID: 4477114
    [No Abstract]   [Full Text] [Related]  

  • 6. Control of heparin therapy in open-heart surgery.
    Jaberi M; Bell WR; Benson DW
    J Thorac Cardiovasc Surg; 1974 Jan; 67(1):133-41. PubMed ID: 4808908
    [No Abstract]   [Full Text] [Related]  

  • 7. Anticoagulant monitoring and neutralization during open heart surgery--a rapid method for measuring heparin and calculating safe reduced protamine doses.
    Umlas J; Taff RH; Gauvin G; Swierk P
    Anesth Analg; 1983 Dec; 62(12):1095-9. PubMed ID: 6650893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass.
    Esposito RA; Culliford AT; Colvin SB; Thomas SJ; Lackner H; Spencer FC
    J Thorac Cardiovasc Surg; 1983 Feb; 85(2):174-85. PubMed ID: 6823136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of blood loss and heparin rebound following cardiopulmonary bypass.
    Pifarre R; Sullivan HJ; Montoya A; Bakhos M; Grieco J; Foy BK; Blakeman B
    Semin Thromb Hemost; 1989 Apr; 15(2):173-7. PubMed ID: 2787532
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of protamine dose assay in reversal of heparin following extracorporeal circulation for open heart surgery.
    Lee CN; Goh BL; Chin LG; Tan C; Woo M; Boey WK; Lee E; Kuah B
    Ann Acad Med Singap; 1990 Jan; 19(1):41-4. PubMed ID: 2327723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Control of heparin and protamine administration (author's transl)].
    Yuge I; Fujii N; Yamada M; Anzai N
    Kyobu Geka; 1979 May; 32(5):337-40. PubMed ID: 459164
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of the Soviet-made microcomputer MK-54 for the calculation of heparin and protamine sulfate doses during operations with artificial circulation].
    Savina ME; Flërov KE
    Anesteziol Reanimatol; 1987; (3):57-9. PubMed ID: 3631636
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of postoperative heparin rebound following cardiopulmonary bypass.
    Pifarré R; Babka R; Sullivan HJ; Montoya A; Bakhos M; El-Etr A
    J Thorac Cardiovasc Surg; 1981 Mar; 81(3):378-81. PubMed ID: 7464201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of the activated coagulation time (ACT) in open heart surgery--comparison between children and adult patients].
    Ohmi M; Tsuboi H; Furukawa S; Mohri H; Seo K
    Kyobu Geka; 1984 Nov; 37(12):945-8. PubMed ID: 6521115
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intra-aortic administration of protamine].
    Iida Y; Tsuchiya K; Sakakibara N; Tomisawa Y
    Kyobu Geka; 1982; 35(9):704-5. PubMed ID: 7176270
    [No Abstract]   [Full Text] [Related]  

  • 16. Heparin rebound. A clinical study in cases of open heart surgery under cardiopulmonary bypass.
    Pardanani DS; Roy C; Sen PK
    J Postgrad Med; 1970 Jan; 16(1):26-32. PubMed ID: 5444602
    [No Abstract]   [Full Text] [Related]  

  • 17. Heparin therapy during extracorporeal circulation. I. Problems inherent in existing heparin protocols.
    Bull BS; Korpman RA; Huse WM; Briggs BD
    J Thorac Cardiovasc Surg; 1975 May; 69(5):674-84. PubMed ID: 1127966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of complement 4 genetic polymorphism on complement activation during cardiopulmonary bypass in open heart surgery among children].
    Zhang S; Li Q; Yao S
    Zhonghua Yi Xue Za Zhi; 2001 Aug; 81(15):918-20. PubMed ID: 11702666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of thromboelastography with heparinase or protamine sulfate added in vitro during heparinized cardiopulmonary bypass.
    Spiess BD; Wall MH; Gillies BS; Fitch JC; Soltow LO; Chandler WL
    Thromb Haemost; 1997 Aug; 78(2):820-6. PubMed ID: 9268178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant?
    Brister SJ; Ofosu FA; Buchanan MR
    Thromb Haemost; 1993 Aug; 70(2):259-62. PubMed ID: 8236131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.